In this video interview, Yael Elish, founder, CEO, StuffThatWorks; and Julie Ross, president, CEO, Advanced Clinical, discuss ...

This year’s conference highlighted a number of critical areas in clinical R&D including financial management, representation, ...

Genomics has long been a primary focus in precision medicine, but other areas of research are increasingly being used to help ...

At the current rate of progress, it will take until 2158 to reach full gender parity based on a global measure of opportunity ...

In this video interview, Yael Elish, founder, CEO, StuffThatWorks; and Julie Ross, president, CEO, Advanced Clinical, ...

Policy change by the Trump administration now allows the agency to post public notices in the Federal Register and advertise ...

Ron Lanton, Partner, Lanton Law, discusses how stakeholders must navigate funding future clinical research amid NIH budget ...

Clinical trials are notoriously expensive, with operational expenses ranging from $50 million to over $115 million. 1 The ...

Phase III REMIX-1 and REMIX-2 trials demonstrated that remibrutinib, an oral BTK inhibitor, significantly reduced chronic ...

Teams must work together with technology solutions and optimize integration to unlock their full potential. Clinical trials ...

A tool-based approach can significantly aid in the harmonization of regulatory requirements, mitigate inadvertent risks, and ...

In this video interview, Vera Pomerantseva, director of product management, RBQM, eClinical Solutions, talks FDA’s latest ...